Research > Neurosciences

Neuroimmunology

Number of publications
123
Publications search

  • Solari, A; Montalban, X; Lechner-Scott, J; Piehl, F; Brochet, B; Langdon, D; Hupperts, R; Selmaj, K; Havrdova, EK; Patti, F; Brieva, L; Maida, EM; Alexandri, N; Smyk, A; Nolting, A; Keller, B

    Improvements in quality of life over 2 years in patients treated with cladribine tablets for highly active relapsing multiple sclerosis: Final analysis of CLARIFY-MS

    MULTIPLE SCLEROSIS JOURNAL 28 203-204. .

  • Martín-Aguilar L.; Presas-Rodriguez S.; Rovira À.; Capellades J.; Massuet-Vilamajó A.; Ramió-Torrentà L.; Tintoré M.; Brieva-Ruiz L.; Moral E.; Cano-Orgaz A.; Blanco Y.; Batlle-Nadal J.; Carmona O.; Gea M.; Hervás-García J.V.; Ramo-Tello C.

    Gadolinium-enhanced brain lesions in multiple sclerosis relapse

    NEUROLOGIA 37 557-563. .

    [doi:10.1016/j.nrl.2021.10.005]

  • Gonzalez-Mingot, C; Lopez-Ortega, R; Brieva-Ruiz, L

    The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2

    NEUROLOGICAL SCIENCES 43 5099-5101. .

    [doi:10.1007/s10072-022-06144-2]

  • Castillo-Trivino, Tamara; Gomez-Ballesteros, Rocio; Borges, Monica; Martin-Martinez, Jesus; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco-Quilez, Maria R.; Garcia-Soto, Julio Dotor; del Campo-Amigo, Maria; Navarro-Canto, Laura; Aguera, Eduardo; Garces-Redondo, Moises; Carmona, Olga; Gabaldon-Torres, Laura; Forero, Lucia; Hervas, Mariona; Mauriño J; Sainz de la Maza S

    Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.

    Multiple Sclerosis and Related Disorders 64 103969-103969. .

    [doi:10.1016/j.msard.2022.103969]

  • Brieva, L; Estruch, BC; Merino, JAG; Meca-Lallana, V; Rio, J; Rodriguez-Antigueedad, A; Aguera, E; Ara, JR; Luque, AA; Garcia, CA; Blanco, Y; Castillo-Trivino, T; Costa-Frossard, L; Platas, MG; Pascual, LL; Llaneza-Gonzalez, M; Gines, MLM; Matias-Guiu, J; Meca-Lallana, JE; Bilbao, MM; Sempere, AP; Romero-Pinel, L; Saiz, A; Moral, E

    Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders 63 -. .

    [doi:10.1016/j.msard.2022.103805]

  • Vermersch P; Brieva-Ruiz L; Fox RJ; Paul F; Ramio-Torrenta L; Schwab M; Moussy A; Mansfield C; Hermine O; Maciejowski M

    Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

    Neurology-Neuroimmunology & Neuroinflammation 9 -. .

    [doi:10.1212/NXI.0000000000001148]

  • Sancho-Saldana, A; Gil Sánchez A; Quirant-Sanchez, B; Nogueras, L; Peralta, S; Solana, MJ; Gonzalez-Mingot, C; Gallego, Y; Quibus, L; Ramo-Tello, C; Presas-Rodriguez, S; Martinez-Caceres, E; Torres, P; Hervas, JV; Valls, J; Brieva, L

    Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

    Journal of Clinical Medicine 11 -. .

    [doi:10.3390/jcm11092509]

  • Fernández-Velasco JI; Monreal E; Kuhle J; Meca-Lallana V; Meca-Lallana J; Izquierdo G; Oreja-Guevara C; Gascón-Giménez F; Sainz de la Maza S; Walo-Delgado PE; Lapuente-Suanzes P; Maceski A; Rodríguez-Martín E; Roldán E; Villarrubia N; Saiz A; Blanco Y; Diaz-Pérez C; Valero-López G; Diaz-Diaz J; Aladro Y; Brieva L; Íñiguez C; González-Suárez I; Rodríguez de Antonio LA; García-Domínguez JM; Sabin J; Llufriu S; Masjuan J; Costa-Frossard L; Villar LM

    Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.

    Frontiers in Immunology 13 842354-842354. .

    [doi:10.3389/fimmu.2022.842354]

  • de la Maza, SS; Maurino, J; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; de Alda, LR; Gómez-Ballesteros, R; Castillo-Triviño, T

    Measuring productivity loss in early relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders 58 -. .

    [doi:10.1016/j.msard.2021.103398]

  • Ramo-Tello C; Blanco Y; Brieva L; Casanova B; Martínez-Cáceres E; Ontaneda D; Ramió-Torrentá L; Rovira À

    Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.

    Journal of Personalized Medicine 12 -. .

    [doi:10.3390/jpm12010006]

  • Granell-Geli, J; Izquierdo-Gracia, C; Selles-Rius, A; Teniente-Serra, A; Presas-Rodriguez, S; Mansilla, MJ; Brieva, L; Sotoca, J; Mane-Martinez, MA; Moral, E; Bragado, I; Goelz, S; Martinez-Caceres, E; Ramo-Tello, C

    Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab

    Journal of Personalized Medicine 11 -. .

    [doi:10.3390/jpm11121347]

  • Munoz-Lopetegi, A; Pujol, M; Gimenez, M; Gaig, C; Brieva, L; Santamaria, J

    Abnormal sleep behavior caused by hypoglycemia

    SLEEP MEDICINE 85 268-270. .

    [doi:10.1016/j.sleep.2021.07.029]